메뉴 건너뛰기




Volumn 795, Issue , 1996, Pages 275-283

Murine models of cancer cytokine gene therapy using interleukin-12

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; NEUTRALIZING ANTIBODY; RECOMBINANT INTERLEUKIN 12;

EID: 0030479888     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52677.x     Document Type: Conference Paper
Times cited : (37)

References (14)
  • 2
    • 0024467154 scopus 로고
    • Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
    • KOBAYASHI, M., L. FITZ, M. RYAN, R. M. HEWICK, S. C. CLARK, S. CHANG, R. LOUDON, F. SHERMAN, B. PERUSSIA & G. TRINCHIERI. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp. Med. 170: 827-845.
    • (1989) J Exp. Med. , vol.170 , pp. 827-845
    • Kobayashi, M.1    Fitz, L.2    Ryan, M.3    Hewick, R.M.4    Clark, S.C.5    Chang, S.6    Loudon, R.7    Sherman, F.8    Perussia, B.9    Trinchieri, G.10
  • 4
    • 0027953555 scopus 로고
    • Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumor growth and induce anti-tumor immunity to a murine melanoma in vivo
    • TAHARA, H., H. J. Z. ZEH III, W. J. STOKUS, I. PAPPO, S. C. WATKINS, U. GUBLER, S. F. WOLF, P. D. ROBBINS & T. M. LOTZE. 1994. Fibroblasts genetically engineered to secrete interleukin-12 can suppress tumor growth and induce anti-tumor immunity to a murine melanoma in vivo. Cancer Res. 54: 182-189.
    • (1994) Cancer Res. , vol.54 , pp. 182-189
    • Tahara, H.1    Zeh III, H.J.Z.2    Stokus, W.J.3    Pappo, I.4    Watkins, S.C.5    Gubler, U.6    Wolf, S.F.7    Robbins, P.D.8    Lotze, T.M.9
  • 9
    • 0029148905 scopus 로고
    • Cancer immunotherapy of established tumors with interleukin-12: Effective delivery by genetically engineered fibroblasts
    • ZITVOGEL, L., H. TAHARA, P. D. ROBBINS, W. J. STORKUS, M. R. CLARKE, M. A. NALESNIK & M. T. LOTZE. 1995. Cancer immunotherapy of established tumors with interleukin-12: Effective delivery by genetically engineered fibroblasts. J. Immunol. 155: 1393-1403.
    • (1995) J. Immunol. , vol.155 , pp. 1393-1403
    • Zitvogel, L.1    Tahara, H.2    Robbins, P.D.3    Storkus, W.J.4    Clarke, M.R.5    Nalesnik, M.A.6    Lotze, M.T.7
  • 10
    • 0026772206 scopus 로고
    • In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors
    • CULVER, K. W., Z. RAM, S. WALLBRIDGE, H. ISHII, E. H. OLDFIELD & R. M. BLEASE. 1992. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science. 256(5063): 1550-1552.
    • (1992) Science. , vol.256 , Issue.5063 , pp. 1550-1552
    • Culver, K.W.1    Ram, Z.2    Wallbridge, S.3    Ishii, H.4    Oldfield, E.H.5    Blease, R.M.6
  • 13
    • 0027963161 scopus 로고
    • Recombinant interleukin-12 administration induces tumor regression in association with interferon-gamma and nitric oxide production
    • NASTALA, C. L., H. EDINGTON, W. STORKUS, T. G. MCKINNEY, H. TAHARA, M. J. BRUNDA, M. K. GATELY, R. SCHREIBER & M. T. LOTZE. 1994. Recombinant interleukin-12 administration induces tumor regression in association with interferon-gamma and nitric oxide production. J. Immunol. 153: 1697-1706.
    • (1994) J. Immunol. , vol.153 , pp. 1697-1706
    • Nastala, C.L.1    Edington, H.2    Storkus, W.3    Mckinney, T.G.4    Tahara, H.5    Brunda, M.J.6    Gately, M.K.7    Schreiber, R.8    Lotze, M.T.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.